Cintas (CTAS) Q3 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 earnings summary
25 Mar, 2026Executive summary
Achieved record third quarter revenue of $2.84 billion, up 8.9% year-over-year, with organic growth of 8.2%.
All-time high gross margins in each of the three route-based businesses, with consolidated gross margin at 51%, up 40 basis points year-over-year.
Operating income grew 8.2% to $659.9 million; adjusted for a prior-year one-time gain, growth was 11%.
Diluted EPS increased 9.7% to $1.24; adjusted EPS growth was 12.7%.
Announced agreement to acquire UniFirst, expected to close in the second half of calendar 2026, with anticipated value creation.
Financial highlights
Net income for the quarter was $502.5 million, up from $463.5 million year-over-year, with net income margin at 17.7%.
Gross margin for Q3 reached $1.45 billion, up 9.8% year-over-year.
Operating income for Q3 was $659.9 million, up 8.2% year-over-year; operating margin was 23.2%.
Free cash flow for the nine months was $1.27 billion, up from $1.23 billion a year ago.
Returned $1.45 billion to shareholders via dividends and buybacks in the first nine months of fiscal 2026.
Outlook and guidance
Fiscal 2026 revenue guidance raised to $11.21–$11.24 billion, representing 8.4%–8.7% growth.
Adjusted diluted EPS guidance increased to $4.86–$4.90, up 10.5%–11.4%.
Guidance assumes constant FX, no future acquisitions, and a 20% effective tax rate.
Fiscal 2026 net interest expense expected at $101 million, up from $95.5 million in 2025 due to refinancing and higher variable rates.
Transaction costs from the UniFirst deal expected to impact EPS by $0.03–$0.04 in fiscal 2026.
Latest events from Cintas
- $5.5B merger delivers $375M synergies, $310/share for UniFirst, closing in H2 2026.CTAS
M&A announcement11 Mar 2026 - Record growth, margin expansion, and a four-for-one stock split highlight strong 2025 outlook.CTAS
Q4 20243 Feb 2026 - Revenue and profit surged, margins expanded, and guidance was raised for fiscal 2025.CTAS
Q1 202520 Jan 2026 - Directors and key proposals were voted on, with all board and management recommendations approved.CTAS
AGM 202418 Jan 2026 - Revenue and net income surged with margin gains and higher full-year guidance.CTAS
Q2 202510 Jan 2026 - Record revenue, margin expansion, and raised guidance highlight strong quarterly performance.CTAS
Q2 20267 Jan 2026 - Q3 revenue and EPS surged, driving higher guidance and strong margin expansion.CTAS
Q3 20256 Jan 2026 - Directors, executive pay, and auditors approved; special meeting proposal rejected; growth plans highlighted.CTAS
AGM 202514 Dec 2025 - Annual meeting covers director elections, pay, equity plan, auditor, and key ESG shareholder proposals.CTAS
Proxy Filing1 Dec 2025